78 related articles for article (PubMed ID: 29317111)
21. Predictors of short-term LAMA ineffectiveness in treatment naïve patients with moderate to severe COPD.
Fijačko V; Labor M; Fijačko M; Škrinjarić-Cincar S; Labor S; Dumbović Dubravčić I; Bačun T; Včev A; Popović-Grle S; Plavec D
Wien Klin Wochenschr; 2018 Apr; 130(7-8):247-258. PubMed ID: 29322375
[TBL] [Abstract][Full Text] [Related]
22. β-Blockers in COPD: A Cohort Study From the TONADO Research Program.
Maltais F; Buhl R; Koch A; Amatto VC; Reid J; Grönke L; Bothner U; Voß F; McGarvey L; Ferguson GT
Chest; 2018 Jun; 153(6):1315-1325. PubMed ID: 29355547
[TBL] [Abstract][Full Text] [Related]
23. Examining 30-day COPD readmissions through the emergency department.
Rezaee ME; Ward CE; Nuanez B; Rezaee DA; Ditkoff J; Halalau A
Int J Chron Obstruct Pulmon Dis; 2018; 13():109-120. PubMed ID: 29343950
[TBL] [Abstract][Full Text] [Related]
24. Recruiting Patients After Hospital Discharge for Acute Exacerbation of COPD: Challenges and Lessons Learned.
Ferguson GT; Beck B; Clerisme-Beaty E; Liu D; Thomashow BM; Wise RA; ZuWallack R; Make BJ
Chronic Obstr Pulm Dis; 2017 Aug; 4(4):265-278. PubMed ID: 29354671
[No Abstract] [Full Text] [Related]
25. Comparison of the in vitro pharmacological profiles of long-acting muscarinic antagonists in human bronchus.
Naline E; Grassin Delyle S; Salvator H; Brollo M; Faisy C; Victoni T; Abrial C; Devillier P
Pulm Pharmacol Ther; 2018 Apr; 49():46-53. PubMed ID: 29337266
[TBL] [Abstract][Full Text] [Related]
26. Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here?
Dekhuijzen R; Lavorini F; Usmani OS; van Boven JFM
J Allergy Clin Immunol Pract; 2018; 6(3):785-793. PubMed ID: 29339126
[TBL] [Abstract][Full Text] [Related]
27. Identification of inhaler technique errors with a routine procedure in Portuguese community pharmacy.
Castel-Branco MM; Fontes A; Figueiredo IV
Pharm Pract (Granada); 2017; 15(4):1072. PubMed ID: 29317923
[TBL] [Abstract][Full Text] [Related]
28. Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease.
Maltais F; O'Donnell D; Gáldiz Iturri JB; Kirsten AM; Singh D; Hamilton A; Tetzlaff K; Zhao Y; Casaburi R
Ther Adv Respir Dis; 2018; 12():1753465818755091. PubMed ID: 29439648
[TBL] [Abstract][Full Text] [Related]
29. Effects of umeclidinium/vilanterol on exercise endurance in COPD: a randomised study.
Riley JH; Kalberg CJ; Donald A; Lipson DA; Shoaib M; Tombs L
ERJ Open Res; 2018 Jan; 4(1):. PubMed ID: 29322050
[TBL] [Abstract][Full Text] [Related]
30. Tiotropium: from COPD to young children with asthma?
Cruz AA
Lancet Respir Med; 2018 Feb; 6(2):80-82. PubMed ID: 29361463
[No Abstract] [Full Text] [Related]
31. Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study.
Bremner PR; Birk R; Brealey N; Ismaila AS; Zhu CQ; Lipson DA
Respir Res; 2018 Jan; 19(1):19. PubMed ID: 29370819
[TBL] [Abstract][Full Text] [Related]
32. Effect of Roflumilast on Airway Blood Flow in COPD: A Pilot Study.
Mendes ES; Rebolledo P; Cadet L; Arana J; Scmid A; Wanner A
Chronic Obstr Pulm Dis; 2017 Aug; 4(4):262-264. PubMed ID: 29354670
[No Abstract] [Full Text] [Related]
33. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes.
Usmani OS; Lavorini F; Marshall J; Dunlop WCN; Heron L; Farrington E; Dekhuijzen R
Respir Res; 2018 Jan; 19(1):10. PubMed ID: 29338792
[TBL] [Abstract][Full Text] [Related]
34. Tiotropium added to low- to medium-dose inhaled corticosteroids (ICS) versus low- to medium-dose ICS alone for adults with mild to moderate uncontrolled persistent asthma: A systematic review and meta-analysis.
Wang L; Zhou R; Xie X
J Asthma; 2019 Jan; 56(1):69-78. PubMed ID: 29420077
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of Tiotropium in Children and Adolescents.
Hamelmann E; Szefler SJ
Drugs; 2018 Mar; 78(3):327-338. PubMed ID: 29368127
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of tiotropium in children aged 1-5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trial.
Vrijlandt EJLE; El Azzi G; Vandewalker M; Rupp N; Harper T; Graham L; Szefler SJ; Moroni-Zentgraf P; Sharma A; Vulcu SD; Sigmund R; Chawes B; Engel M; Bisgaard H
Lancet Respir Med; 2018 Feb; 6(2):127-137. PubMed ID: 29361462
[TBL] [Abstract][Full Text] [Related]
37. Adolescent and caregivers' experiences of electronic adherence assessment in paediatric problematic severe asthma.
Stewart AC; Gannon KN; Beresford F; Fleming L
J Child Health Care; 2018 Jun; 22(2):238-250. PubMed ID: 29325420
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
